HRTS Tema Cardiovascular and Metabolic ETF

44

NASDAQ | ETF

Price
$28.36
Increased by +1.23%
Dollar volume (20D)
288.40 K
ADR%
2.37
Healthcare - 100.00%Basic Materials - 0.00%Communication Services - 0.00%Consumer Cyclicals - 0.00%Consumer Defensive - 0.00%Energy - 0.00%Financial Services - 0.00%Industrials - 0.00%Real Estate - 0.00%Technology - 0.00%Utilities - 0.00%
Healthcare - 100.00%
Basic Materials - 0.00%
Communication Services - 0.00%
Consumer Cyclicals - 0.00%
Consumer Defensive - 0.00%
Energy - 0.00%
Financial Services - 0.00%
Industrials - 0.00%
Real Estate - 0.00%
Technology - 0.00%
Utilities - 0.00%

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions.

The fund generally is expected to consist of more than 15 companies but not more than 100 companies.

The fund is non-diversified.

Top 20 Holdings

Asset Name Sector Industry Weight
LLY Eli Lilly and Company Healthcare Drug Manufacturers - General 10.72%
UNH UnitedHealth Group Incorporated Healthcare Healthcare Plans 5.28%
BBIO BridgeBio Pharma Inc Healthcare Biotechnology 4.29%
AZN AstraZeneca PLC Healthcare Drug Manufacturers - General 4.09%
ABT Abbott Laboratories Healthcare Medical Devices 4.02%
0QIU Novo Nordisk A/S Class B 3.98%
NOVO-B Novo Nordisk A/S Healthcare Biotechnology 3.94%
RHHBY Roche Holding Ltd ADR Healthcare Drug Manufacturers - General 3.87%
VRTX Vertex Pharmaceuticals Inc Healthcare Biotechnology 3.53%
NOVN Novartis AG Healthcare Drug Manufacturers - General 3.14%
GILD Gilead Sciences Inc Healthcare Drug Manufacturers - General 3.09%
BSX Boston Scientific Corp Healthcare Medical Devices 3.03%
MDT Medtronic PLC Healthcare Medical Devices 2.96%
4519 Chugai Pharmaceutical Co. Ltd. Healthcare Drug Manufacturers - General 2.84%
CRNX Crinetics Pharmaceuticals Inc Healthcare Biotechnology 2.78%
TMO Thermo Fisher Scientific Inc Healthcare Diagnostics & Research 2.77%
MRK Merck & Company Inc Healthcare Drug Manufacturers - General 2.50%
BMY Bristol-Myers Squibb Company Healthcare Drug Manufacturers - General 2.23%
CYTK Cytokinetics Inc Healthcare Biotechnology 2.20%
ABBV AbbVie Inc Healthcare Drug Manufacturers - General 2.11%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY